Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $24.4250 (1.31%) ($24.4250 - $24.4250) on Thu. Aug. 5, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.01% (three month average) | RSI | 21 | Latest Price | $24.4250(1.31%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -7.6% a day on average for past five trading days. | Weekly Trend | TGTX declines -14.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(68%) ARKG(63%) ARKK(59%) IWO(59%) IBB(58%) | Factors Impacting TGTX price | TGTX will decline at least -2.005% in a week (0% probabilities). VIXM(-46%) VXX(-39%) UUP(-19%) UNG(-4%) TLT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.005% (StdDev 4.01%) | Hourly BBV | -0.5 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $5.12(-79.04%) | Resistance Level | $34.53 | 5 Day Moving Average | $27.24(-10.33%) | 10 Day Moving Average | $31.27(-21.89%) | 20 Day Moving Average | $34.53(-29.26%) | To recent high | -41.2% | To recent low | 1.3% | Market Cap | $3.093b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |